Agata Rembielak

1.4k total citations
52 papers, 654 citations indexed

About

Agata Rembielak is a scholar working on Oncology, Epidemiology and Radiation. According to data from OpenAlex, Agata Rembielak has authored 52 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Epidemiology and 20 papers in Radiation. Recurrent topics in Agata Rembielak's work include Advanced Radiotherapy Techniques (20 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Cutaneous Melanoma Detection and Management (11 papers). Agata Rembielak is often cited by papers focused on Advanced Radiotherapy Techniques (20 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Cutaneous Melanoma Detection and Management (11 papers). Agata Rembielak collaborates with scholars based in United Kingdom, United States and Canada. Agata Rembielak's co-authors include Tony Woo, D. Delishaj, Luca Tagliaferri, Elizabeth Barnes, José Luis Guinot, György Kovács, Víctor González‐Pérez, Vincenzo Valentini, B. Guix and Janusz Skowronek and has published in prestigious journals such as British Journal of Dermatology, Journal of Proteome Research and Radiotherapy and Oncology.

In The Last Decade

Agata Rembielak

43 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agata Rembielak United Kingdom 13 317 259 194 133 128 52 654
Bindu V. Manyam United States 14 197 0.6× 200 0.8× 133 0.7× 67 0.5× 127 1.0× 35 563
Orla McArdle Ireland 13 137 0.4× 154 0.6× 62 0.3× 157 1.2× 141 1.1× 39 832
Ian R. Campbell United Kingdom 7 100 0.3× 118 0.5× 43 0.2× 49 0.4× 73 0.6× 9 542
J. H. Shepherd United Kingdom 18 179 0.6× 217 0.8× 20 0.1× 85 0.6× 125 1.0× 43 1.2k
George Shenouda Canada 15 83 0.3× 72 0.3× 25 0.1× 224 1.7× 275 2.1× 40 555
Bin Qiu China 14 104 0.3× 124 0.5× 18 0.1× 50 0.4× 113 0.9× 40 398
Joaquin G. Mira United States 15 259 0.8× 387 1.5× 15 0.1× 120 0.9× 405 3.2× 32 803
Hanna M. Mathéron Netherlands 11 82 0.3× 108 0.4× 12 0.1× 50 0.4× 114 0.9× 15 425
Graeme Dickie Australia 14 216 0.7× 361 1.4× 128 0.7× 5 0.0× 152 1.2× 24 666
Elias Mallas Greece 15 310 1.0× 199 0.8× 9 0.0× 32 0.2× 130 1.0× 25 621

Countries citing papers authored by Agata Rembielak

Since Specialization
Citations

This map shows the geographic impact of Agata Rembielak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata Rembielak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata Rembielak more than expected).

Fields of papers citing papers by Agata Rembielak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agata Rembielak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata Rembielak. The network helps show where Agata Rembielak may publish in the future.

Co-authorship network of co-authors of Agata Rembielak

This figure shows the co-authorship network connecting the top 25 collaborators of Agata Rembielak. A scholar is included among the top collaborators of Agata Rembielak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agata Rembielak. Agata Rembielak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guinot, José Luis, Francesco Bussu, Víctor González‐Pérez, et al.. (2024). GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR. Radiotherapy and Oncology. 201. 110533–110533. 7 indexed citations
2.
Fionda, Bruno, Alessandro Di Stefani, Valentina Lancellotta, et al.. (2024). The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review. Journal of Clinical Medicine. 13(6). 1798–1798. 8 indexed citations
3.
Joseph, Kurian, Michael Veness, Elizabeth Barnes, & Agata Rembielak. (2023). Radiotherapy in Skin Cancer. PubMed. 29(24). 1041–2.
5.
Rembielak, Agata, et al.. (2023). Advances in Skin Brachytherapy: Cosmesis and Function Preservation. Clinical Oncology. 35(8). 507–515. 8 indexed citations
6.
Chan, Adrian Wai, Henry C. Y. Wong, Martin Klein, et al.. (2023). Latest clinical research in leptomeningeal disease (LMD)—a narrative review. Annals of Palliative Medicine. 12(6). 1215–1231. 1 indexed citations
7.
Rembielak, Agata, Thomas Yau, Baran Akagündüz, et al.. (2023). Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients. Journal of Geriatric Oncology. 14(4). 101502–101502. 10 indexed citations
8.
Swain, Monali, et al.. (2023). Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy. Clinical Oncology. 35(8). 489–496. 12 indexed citations
9.
González‐Pérez, Víctor, Agata Rembielak, José Luis Guinot, et al.. (2022). H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds. Radiotherapy and Oncology. 175. 122–132. 9 indexed citations
10.
Tsao, May, Elizabeth Barnes, Irene Karam, & Agata Rembielak. (2022). Hypofractionated Radiation Therapy in Keratinocyte Carcinoma. Clinical Oncology. 34(5). e218–e224.
11.
Rembielak, Agata, Andrew Sykes, Kate Fife, Amarnath Challapalli, & Jenny Nobes. (2020). Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic. Clinical Oncology. 32(7). 417–419. 4 indexed citations
12.
Keohane, Stephen, P.G. Budny, O.M. Dolan, et al.. (2020). British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020*. British Journal of Dermatology. 184(3). 401–414. 56 indexed citations
13.
Dennis, Kristopher, Rasha Kamel, T. Barnes, et al.. (2020). Rapid Access Palliative Radiotherapy Programmes. Clinical Oncology. 32(11). 704–712. 22 indexed citations
14.
Tagliaferri, Luca, Valentina Lancellotta, Stefano Gentileschi, et al.. (2019). Cosmetic assessment in brachytherapy (interventional radiotherapy) for breast cancer: A multidisciplinary review. Brachytherapy. 18(5). 635–644. 3 indexed citations
15.
Guinot, José Luis, Agata Rembielak, José Pérez‐Calatayud, et al.. (2018). GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiotherapy and Oncology. 126(3). 377–385. 118 indexed citations
16.
Rembielak, Agata, et al.. (2014). Utility of radiotherapy for treatment of basal cell carcinoma: a review. British Journal of Dermatology. 171(5). 968–973. 48 indexed citations
17.
Makarewicz, Roman, et al.. (2007). Estimation of the α/β ratio for lower lip cancer treated with interstitial HDR brachytherapy. Reports of Practical Oncology & Radiotherapy. 12(4). 207–210. 1 indexed citations
18.
Rembielak, Agata, et al.. (2002). IMRT in clinical practice - introduction of new QA procedures. Nowotwory Journal of Oncology. 52(1). 41–41. 1 indexed citations
19.
Rembielak, Agata & Krzysztof Ślosarek. (2002). Intensity modulated radiation therapy (IMRT) in prostate cancer. Nowotwory Journal of Oncology. 52(2). 150–150. 1 indexed citations
20.
Ślosarek, Krzysztof, et al.. (2001). 82. IBU and CT based conformal HDR brachytherapy. Reports of Practical Oncology & Radiotherapy. 6(1). 64–64.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026